Trial Parameters
Condition ADHD
Sponsor Sherief Abd-Elsalam
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 40
Sex ALL
Min Age 2 Years
Max Age 18 Years
Start Date 2018-11-01
Completion 2030-12-01
Interventions
AtomoxetineCoenzyme Q
Brief Summary
Role of Coenzyme Q in ADHD in Children
Eligibility Criteria
Inclusion Criteria: * Patients with ADHD Exclusion Criteria: * Comorbidities like Autism, Anxiety, Obsessive compulsive disorder.